Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2005
10/06/2005US20050220761 stimulating neural progenitor cells by culturing the cells ex vivo with a composition comprising IL6R/IL6 chimera, fused protein, functional derivative, circularly permutated derivative prior to transplantation; used for loss or atrophy of neurons caused by aging or by a neurological disease
10/06/2005US20050220760 Novel immunotherapy
10/06/2005US20050220759 Treating multiple sclerosis by orally administering an excipient and a RANTES polypeptide or a macrophage inflammatory protein; preventing autoimmune and inflammatory diseases and bacterial and viral infections
10/06/2005US20050220758 Lyophilised preparation comprising immunocytokines
10/06/2005US20050220757 Chemokine mutants acting as chemokine antagonists
10/06/2005US20050220754 Vitamin directed targeting therapy
10/06/2005US20050220734 Therapy for melanin related afflictions
10/06/2005US20050220722 Method of decreasing fasting sugars and weight gains in diabetic patients
10/06/2005US20050220708 Skin test for detecting non-allergic hypersensitivity
10/06/2005CA2561696A1 Novel modified galectin 9 proteins and use thereof
10/06/2005CA2561495A1 Truncated dance, dance complex and method of using these
10/06/2005CA2560930A1 Methods of protein fractionation using high performance tangential flow filtration
10/06/2005CA2560902A1 Treatment of neurological conditions using complement c5a receptor modulators
10/06/2005CA2560508A1 Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation
10/06/2005CA2560241A1 Carbohydrate-derivatized liposomes for targeting cellular carbohydrate recognition domains of ctl/ctld lectins, and intracellular delivery of therapeutically active compounds
10/06/2005CA2558738A1 Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
10/06/2005CA2557782A1 Glycol linked fgf-21 compounds
10/06/2005CA2557677A1 In vitro test system for predicting patient tolerability of therapeutic agents
10/06/2005CA2554535A1 Uses of galectin-2
10/05/2005EP1582591A2 Sirna and their use for knock down expression of porcine endogenous retrovirus
10/05/2005EP1582586A1 Apoptosis-associated protein and use thereof
10/05/2005EP1582216A1 Remedy for pemphigoid
10/05/2005EP1582215A1 Method of inhibiting cell death, cell death inhibitor and remedy for disease caused by cell death containing the cell death inhibitor
10/05/2005EP1582204A2 Echinocandin pharmaceutical formulations containing micelle-forming surfactants
10/05/2005EP1581904A2 Novel proteins with altered immunogenicity
10/05/2005EP1581812A2 Compositions and methods for diagnosing and treating colon cancers
10/05/2005EP1581790A2 Peptides that home to tumor lymphatic vasculature and methods of using same
10/05/2005EP1581656A2 MODULATION OF HIF1a AND HIF2a EXPRESSION
10/05/2005EP1581649A2 Binding agents which inhibit myostatin
10/05/2005EP1581648A2 G protein coupled receptors and uses thereof
10/05/2005EP1581635A2 Sirna-mediated gene silencing
10/05/2005EP1581634A2 A method for treatment of drug addiction and for screening of pharmaceutical agents therefor
10/05/2005EP1581631A2 Interferon variants with improved properties
10/05/2005EP1581625A2 Junctional adhesion molecule splice variants
10/05/2005EP1581623A2 Trefoil domain-containing polypeptides and uses thereof
10/05/2005EP1581618A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/05/2005EP1581616A2 Novel proteins and nucleic acids encoding same
10/05/2005EP1581615A2 Peptide conjugated anti-cancer prodrugs
10/05/2005EP1581614A2 Nucleotide sequences for gene regulation and methods of use thereof
10/05/2005EP1581560A1 Anti-idiotypic antibodies against factor viii inhibitor and uses thereof
10/05/2005EP1581557A2 Metastin derivatives and their use
10/05/2005EP1581556A2 Bactericidal, anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp)
10/05/2005EP1581552A2 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
10/05/2005EP1581550A2 Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands, particulary of bothrops jararaca, vasopeptidases inhibitors, evasins, their analogues, derivatives and products associated, thereof. for development of aplications and use in chronic-degenerative diseases
10/05/2005EP1581549A2 Modulation of acteyl-coa acetyltransferase 2 expression
10/05/2005EP1581307A2 Irs modulators
10/05/2005EP1581255A1 An acqueous pharmaceutical formulation comprising the thrombin inhibitor melagatran and use of the formulation in the manufacture of a medicament for use by nasal administration in treating thromboembolism
10/05/2005EP1581254A2 Pharmacological vitreolysis
10/05/2005EP1581253A2 Butyrylcholinesterase variants that alter the activity of chemotherapeutic agents
10/05/2005EP1581251A2 Human growth hormone crystals and methods for preparing them
10/05/2005EP1581250A2 Oral formulations for proteins and polypeptides
10/05/2005EP1581249A2 Methods of treating neurological conditions with hematopoeitic growth factors
10/05/2005EP1581248A2 Modification of feeding behaviour and weight control by oxyntomodulin
10/05/2005EP1581247A1 Methods and compositions for treating polycystic ovary syndrome
10/05/2005EP1581246A2 Compositions for the treatment and prevention of nephropathy
10/05/2005EP1581245A2 Compositions and methods for enhanced mucosal delivery of y2 receptor-binding peptides and methods for treating and preventing obesity
10/05/2005EP1581244A1 Novel therapeutic targets in cancer
10/05/2005EP1581243A2 Oral lactoferrin in the treatment of sepsis
10/05/2005EP1581242A2 Compositions and methods for modifying toxic effects of proteinaceous compounds
10/05/2005EP1581241A2 Stimulation of vascularization with vegf-b
10/05/2005EP1581203A1 Therapeutic formulations for the treatment of beta-amyloid related diseases
10/05/2005EP1581200A2 Compositions and methods for nutrition supplementation
10/05/2005EP1581177A2 Cutaneous metabolic bio-activator
10/05/2005EP1581169A2 Compositions and methods for the treatment of natural killer cell related diseases
10/05/2005EP1581166A2 Cytokine inhibition of eosinophils
10/05/2005EP1581119A2 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
10/05/2005EP1581095A2 Therapeutic methods for reducing fat deposition and treating associated conditions
10/05/2005EP1581066A1 A method of improving nutrient utilisation by a mammal and a composition for use therein
10/05/2005EP1385536B1 Preparations containing a combination of vitamin e and afamin
10/05/2005EP1333854A4 The use of bacterial phage associated lytic enzymes to prevent food poisoning
10/05/2005EP1294393B1 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment and diagnosis of athersclerosis
10/05/2005EP1248654B1 Intra-tumoral administration of il-12 encoding naked nucleic acid molecules
10/05/2005EP1124571B1 Use of growth hormone or analogues thereof for the treatment of mammals with familial hypercholesterolemia
10/05/2005EP1077936B1 Novel analogs of 16-hydroxyeicosatetraenoic acid
10/05/2005EP1057026A4 Circulating insulin-like growth factor-i and prostate cancer risk
10/05/2005EP1001977B1 Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors
10/05/2005EP0914157B1 Anti-tnf antibodies / tnf receptor and methotrexate in the treatment of autoimmune disease
10/05/2005EP0862455A4 Interferon-polymer conjugates and process for preparing the same
10/05/2005EP0775110B1 Arylthio compounds as antibacterial and antiviral agents
10/05/2005CN1678734A Differentiation modulating agents and uses therefor
10/05/2005CN1678636A Thrombus-resolving and anticoagulation double function fusion protein and use thereof
10/05/2005CN1678632A A genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish
10/05/2005CN1678631A Osteoinductive biomaterials
10/05/2005CN1678630A HCV fusion proteins with modified NS3 domains
10/05/2005CN1678628A Stress proteins and peptides and methods of use thereof
10/05/2005CN1678627A Novel depsipeptide compound
10/05/2005CN1678621A Modified 2' and 3' -nucleoside produgs for treating flaviridae infections
10/05/2005CN1678612A Viral inhibitors
10/05/2005CN1678344A Human papilloma virus treatment
10/05/2005CN1678342A Treatment for eye disorder
10/05/2005CN1678341A Use of erythopoietin
10/05/2005CN1678339A Synergistic combination of silk proteins
10/05/2005CN1678338A Method and composition for regulating the activity of regulatory T cells
10/05/2005CN1678337A Amelioration of effects of cigarette smoke
10/05/2005CN1678336A Treatment of disease by inducing cell apoptosis
10/05/2005CN1678326A 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
10/05/2005CN1678188A Nucleic acid compositions for stimulating immune responses
10/05/2005CN1676610A Novel penicillium marneffei PPIase II, its coding sequence and use
10/05/2005CN1676609A Novel penicillium marnffei PPIase II, its coding sequence and use
10/05/2005CN1676608A Novel penicillium marneffei ERG1 gene, its coding protein and use
1 ... 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 ... 3163